M&T Bank Corp Boosts Stock Holdings in Phreesia, Inc. (NYSE:PHR)

M&T Bank Corp raised its position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 56.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,939 shares of the company's stock after acquiring an additional 19,812 shares during the period. M&T Bank Corp owned approximately 0.09% of Phreesia worth $1,382,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of PHR. R Squared Ltd bought a new stake in Phreesia during the fourth quarter worth approximately $30,000. BankPlus Trust Department purchased a new stake in shares of Phreesia in the fourth quarter worth approximately $34,000. Venturi Wealth Management LLC bought a new stake in shares of Phreesia during the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC boosted its holdings in Phreesia by 154.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company's stock valued at $89,000 after acquiring an additional 2,090 shares during the period. Finally, XTX Topco Ltd bought a new position in Phreesia in the 3rd quarter valued at $247,000. 92.10% of the stock is currently owned by institutional investors.

Phreesia Stock Down 0.3 %

PHR stock traded down $0.08 during trading on Friday, reaching $25.37. 804,595 shares of the company traded hands, compared to its average volume of 432,702. The business has a 50 day simple moving average of $27.32 and a 200 day simple moving average of $24.00. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The company has a market capitalization of $1.47 billion, a price-to-earnings ratio of -17.26 and a beta of 1.03.

Remove Ads

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same quarter in the previous year, the firm earned ($0.58) EPS. The company's quarterly revenue was up 16.6% compared to the same quarter last year. On average, equities research analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Insider Transactions at Phreesia

In related news, General Counsel Allison C. Hoffman sold 3,495 shares of the company's stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $24.88, for a total transaction of $86,955.60. Following the transaction, the general counsel now directly owns 116,296 shares of the company's stock, valued at $2,893,444.48. This represents a 2.92 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, COO Evan Roberts sold 2,873 shares of the firm's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $76,450.53. Following the completion of the sale, the chief operating officer now directly owns 779,993 shares of the company's stock, valued at approximately $20,755,613.73. This represents a 0.37 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 163,322 shares of company stock valued at $4,631,915. Corporate insiders own 5.80% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on PHR. JMP Securities reiterated a "market outperform" rating and set a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Piper Sandler reissued an "overweight" rating and issued a $33.00 price objective (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Canaccord Genuity Group upped their target price on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday. Truist Financial lifted their price target on shares of Phreesia from $31.00 to $34.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. Finally, Citigroup boosted their price target on Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a report on Friday, January 10th. Thirteen analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has an average rating of "Buy" and a consensus price target of $31.23.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.